At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits
consulate in just 5 months2:135 hours ago Unprecedented: OpenAI goes rogue, hacks into another AI company during cybersecurity test4:5711 hours ago Business Matters: Oil prices reverse sharp gains as U.S., Iran pause strikes2:1811 hours ago Pear Lake Creek fire forces 70 Mile House evacuation4:4911 hours ago Sponsored Content Global National Global National: July 2721:417 hours ago Global National: July 2622:101 day ago Global National: July 2521:582 days ago Global National: July 2422:112 days ago Global National: July 2322:154 days ago Global National: July 2222:075 days ago Global National: July 2122:126 days ago Global National: July 2023:281 week ago Global National: July 19, 202622:081 week ago Global National: July 18, 202621:261 week ago Trending Global News at 6 Toronto: July 2612:051 day ago Toronto mayor welcomes FIFA decision to allow soft water bottles at World Cup matches0:472 months ago Olivia Chow finally confirms shes running for a second term at Torontos Mayor2:292 months ago Toronto council pushes to keep FIFA Fan Fest free, but challenges remain2:013 months ago Toronto fire crews melt Drake ice sculpture2:163 months ago Toronto man who killed 2 strangers 2 days apart found guilty of first-degree murder2:061 month ago Toronto kicks-off spring cleanup campaign1:393 months ago Toronto man found guilty of murdering husband in 20212:051 month ago U.S
GLP-1 Drug Risks and Side Effects GLP-1 drugs are associated with a wide variety of side effects
Formularies for plans available in 2024 were extracted from addresses listed in CMS Machine Readable URL File Public on February 28, 2024
